Cargando…

Tick-borne encephalitis virus induces chemokine RANTES expression via activation of IRF-3 pathway

BACKGROUND: Tick-borne encephalitis virus (TBEV) is one of the most important flaviviruses that targets the central nervous system (CNS) and causes encephalitides in humans. Although neuroinflammatory mechanisms may contribute to brain tissue destruction, the induction pathways and potential roles o...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaowei, Zheng, Zhenhua, Liu, Xijuan, Shu, Bo, Mao, Panyong, Bai, Bingke, Hu, Qinxue, Luo, Minhua, Ma, Xiaohe, Cui, Zongqiang, Wang, Hanzhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004318/
https://www.ncbi.nlm.nih.gov/pubmed/27576490
http://dx.doi.org/10.1186/s12974-016-0665-9
_version_ 1782450781712023552
author Zhang, Xiaowei
Zheng, Zhenhua
Liu, Xijuan
Shu, Bo
Mao, Panyong
Bai, Bingke
Hu, Qinxue
Luo, Minhua
Ma, Xiaohe
Cui, Zongqiang
Wang, Hanzhong
author_facet Zhang, Xiaowei
Zheng, Zhenhua
Liu, Xijuan
Shu, Bo
Mao, Panyong
Bai, Bingke
Hu, Qinxue
Luo, Minhua
Ma, Xiaohe
Cui, Zongqiang
Wang, Hanzhong
author_sort Zhang, Xiaowei
collection PubMed
description BACKGROUND: Tick-borne encephalitis virus (TBEV) is one of the most important flaviviruses that targets the central nervous system (CNS) and causes encephalitides in humans. Although neuroinflammatory mechanisms may contribute to brain tissue destruction, the induction pathways and potential roles of specific chemokines in TBEV-mediated neurological disease are poorly understood. METHODS: BALB/c mice were intracerebrally injected with TBEV, followed by evaluation of chemokine and cytokine profiles using protein array analysis. The virus-infected mice were treated with the CC chemokine antagonist Met-RANTES or anti-RANTES mAb to determine the role of RANTES in affecting TBEV-induced neurological disease. The underlying signaling mechanisms were delineated using RANTES promoter luciferase reporter assay, siRNA-mediated knockdown, and pharmacological inhibitors in human brain-derived cell culture models. RESULTS: In a mouse model, pathological features including marked inflammatory cell infiltrates were observed in brain sections, which correlated with a robust up-regulation of RANTES within the brain but not in peripheral tissues and sera. Antagonizing RANTES within CNS extended the survival of mice and reduced accumulation of infiltrating cells in the brain after TBEV infection. Through in vitro studies, we show that virus infection up-regulated RANTES production at both mRNA and protein levels in human brain-derived cell lines and primary progenitor-derived astrocytes. Furthermore, IRF-3 pathway appeared to be essential for TBEV-induced RANTES production. Site mutation of an IRF-3-binding motif abrogated the RANTES promoter activity in virus-infected brain cells. Moreover, IRF-3 was activated upon TBEV infection as evidenced by phosphorylation of TBK1 and IRF-3, while blockade of IRF-3 activation drastically reduced virus-induced RANTES expression. CONCLUSIONS: Our findings together provide insights into the molecular mechanism underlying RANTES production induced by TBEV, highlighting its potential importance in the process of neuroinflammatory responses to TBEV infection. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12974-016-0665-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5004318
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50043182016-08-31 Tick-borne encephalitis virus induces chemokine RANTES expression via activation of IRF-3 pathway Zhang, Xiaowei Zheng, Zhenhua Liu, Xijuan Shu, Bo Mao, Panyong Bai, Bingke Hu, Qinxue Luo, Minhua Ma, Xiaohe Cui, Zongqiang Wang, Hanzhong J Neuroinflammation Research BACKGROUND: Tick-borne encephalitis virus (TBEV) is one of the most important flaviviruses that targets the central nervous system (CNS) and causes encephalitides in humans. Although neuroinflammatory mechanisms may contribute to brain tissue destruction, the induction pathways and potential roles of specific chemokines in TBEV-mediated neurological disease are poorly understood. METHODS: BALB/c mice were intracerebrally injected with TBEV, followed by evaluation of chemokine and cytokine profiles using protein array analysis. The virus-infected mice were treated with the CC chemokine antagonist Met-RANTES or anti-RANTES mAb to determine the role of RANTES in affecting TBEV-induced neurological disease. The underlying signaling mechanisms were delineated using RANTES promoter luciferase reporter assay, siRNA-mediated knockdown, and pharmacological inhibitors in human brain-derived cell culture models. RESULTS: In a mouse model, pathological features including marked inflammatory cell infiltrates were observed in brain sections, which correlated with a robust up-regulation of RANTES within the brain but not in peripheral tissues and sera. Antagonizing RANTES within CNS extended the survival of mice and reduced accumulation of infiltrating cells in the brain after TBEV infection. Through in vitro studies, we show that virus infection up-regulated RANTES production at both mRNA and protein levels in human brain-derived cell lines and primary progenitor-derived astrocytes. Furthermore, IRF-3 pathway appeared to be essential for TBEV-induced RANTES production. Site mutation of an IRF-3-binding motif abrogated the RANTES promoter activity in virus-infected brain cells. Moreover, IRF-3 was activated upon TBEV infection as evidenced by phosphorylation of TBK1 and IRF-3, while blockade of IRF-3 activation drastically reduced virus-induced RANTES expression. CONCLUSIONS: Our findings together provide insights into the molecular mechanism underlying RANTES production induced by TBEV, highlighting its potential importance in the process of neuroinflammatory responses to TBEV infection. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12974-016-0665-9) contains supplementary material, which is available to authorized users. BioMed Central 2016-08-30 /pmc/articles/PMC5004318/ /pubmed/27576490 http://dx.doi.org/10.1186/s12974-016-0665-9 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Zhang, Xiaowei
Zheng, Zhenhua
Liu, Xijuan
Shu, Bo
Mao, Panyong
Bai, Bingke
Hu, Qinxue
Luo, Minhua
Ma, Xiaohe
Cui, Zongqiang
Wang, Hanzhong
Tick-borne encephalitis virus induces chemokine RANTES expression via activation of IRF-3 pathway
title Tick-borne encephalitis virus induces chemokine RANTES expression via activation of IRF-3 pathway
title_full Tick-borne encephalitis virus induces chemokine RANTES expression via activation of IRF-3 pathway
title_fullStr Tick-borne encephalitis virus induces chemokine RANTES expression via activation of IRF-3 pathway
title_full_unstemmed Tick-borne encephalitis virus induces chemokine RANTES expression via activation of IRF-3 pathway
title_short Tick-borne encephalitis virus induces chemokine RANTES expression via activation of IRF-3 pathway
title_sort tick-borne encephalitis virus induces chemokine rantes expression via activation of irf-3 pathway
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004318/
https://www.ncbi.nlm.nih.gov/pubmed/27576490
http://dx.doi.org/10.1186/s12974-016-0665-9
work_keys_str_mv AT zhangxiaowei tickborneencephalitisvirusinduceschemokinerantesexpressionviaactivationofirf3pathway
AT zhengzhenhua tickborneencephalitisvirusinduceschemokinerantesexpressionviaactivationofirf3pathway
AT liuxijuan tickborneencephalitisvirusinduceschemokinerantesexpressionviaactivationofirf3pathway
AT shubo tickborneencephalitisvirusinduceschemokinerantesexpressionviaactivationofirf3pathway
AT maopanyong tickborneencephalitisvirusinduceschemokinerantesexpressionviaactivationofirf3pathway
AT baibingke tickborneencephalitisvirusinduceschemokinerantesexpressionviaactivationofirf3pathway
AT huqinxue tickborneencephalitisvirusinduceschemokinerantesexpressionviaactivationofirf3pathway
AT luominhua tickborneencephalitisvirusinduceschemokinerantesexpressionviaactivationofirf3pathway
AT maxiaohe tickborneencephalitisvirusinduceschemokinerantesexpressionviaactivationofirf3pathway
AT cuizongqiang tickborneencephalitisvirusinduceschemokinerantesexpressionviaactivationofirf3pathway
AT wanghanzhong tickborneencephalitisvirusinduceschemokinerantesexpressionviaactivationofirf3pathway